299 related articles for article (PubMed ID: 12458354)
1. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
Höffken G; Gillissen A
Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
[TBL] [Abstract][Full Text] [Related]
3. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
Vogel GE
Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
[TBL] [Abstract][Full Text] [Related]
7. Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.
Schmidt RE
Med Microbiol Immunol; 2002 Dec; 191(3-4):175-9. PubMed ID: 12458355
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA
An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008
[TBL] [Abstract][Full Text] [Related]
11. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
[TBL] [Abstract][Full Text] [Related]
12. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
Monto AS; Pichichero ME; Blanckenberg SJ; Ruuskanen O; Cooper C; Fleming DM; Kerr C
J Infect Dis; 2002 Dec; 186(11):1582-8. PubMed ID: 12447733
[TBL] [Abstract][Full Text] [Related]
13. Zanamivir. No noticeable progress against influenza.
Can Fam Physician; 2000 Oct; 46():2003-8, 2012-8. PubMed ID: 11184246
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
Ison MG; Gnann JW; Nagy-Agren S; Treannor J; Paya C; Steigbigel R; Elliott M; Weiss HL; Hayden FG;
Antivir Ther; 2003 Jun; 8(3):183-90. PubMed ID: 12924534
[TBL] [Abstract][Full Text] [Related]
15. Zanamivir: new preparation. No tangible progress against influenza.
Prescrire Int; 2000 Feb; 9(45):199-202. PubMed ID: 11503795
[TBL] [Abstract][Full Text] [Related]
16. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
[TBL] [Abstract][Full Text] [Related]
17. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
Johny AA; Clark A; Price N; Carrington D; Oakhill A; Marks DI
Bone Marrow Transplant; 2002 Jan; 29(2):113-5. PubMed ID: 11850704
[TBL] [Abstract][Full Text] [Related]
18. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
[TBL] [Abstract][Full Text] [Related]
19. Updated treatment for influenza A and B.
Montalto NJ; Gum KD; Ashley JV
Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
[TBL] [Abstract][Full Text] [Related]
20. [symbol: see text] Zanamivir for influenza.
Drug Ther Bull; 1999 Nov; 37(11):81-4. PubMed ID: 10696691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
